UniQuest Pty Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:UniQuest Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013436
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract research, service provision business, collaborative research and development, license and option to license agreements, professional consultancy, and expert opinion services. The company serves health, engineering, information and communications technology, science, and social enterprise sectors. It also serves researchers and start-up companies. UniQuest is headquartered in Brisbane, Queensland, Australia.

UniQuest Pty Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
UniQuest Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Spinifex Pharma Raises US$45 Million In Series C Financing 10
Spinifex Pharma Secures An Additional US$6.5 Million In Series B Financing 12
Partnerships 14
Preveceutical Medical to Enter into Agreement with UniQuest 14
PreveCeutical Enters into Research and Option Agreement with UniQuest 15
Janssen Cilag Enters into Agreement with UniQuest 16
UniQuest Enters into Drug Discovery Agreement with AstraZeneca 17
Emory University Enters Into Joint Venture With UniQuest To Form Que Oncology 18
UniQuest Partners With Axiom Molecular 19
UniQuest Enters Into R&D Agreement With Axiom Molecular For Radiopharmaceuticals 20
Dendright Enters Into Research Agreement With Janssen-Cilag 21
Licensing Agreements 22
Inflazome Enters into Licensing Agreement with Uniquest 22
Organovo Enters into Licensing Agreement with UniQuest 23
Ultragenyx Pharma Enters into Licensing Agreement with UniQuest for Triheptanoin 24
UniQuest Pty Ltd – Key Competitors 25
UniQuest Pty Ltd – Key Employees 26
UniQuest Pty Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Key Facts 2
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
UniQuest Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
UniQuest Pty Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
UniQuest Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Spinifex Pharma Raises US$45 Million In Series C Financing 10
Spinifex Pharma Secures An Additional US$6.5 Million In Series B Financing 12
Preveceutical Medical to Enter into Agreement with UniQuest 14
PreveCeutical Enters into Research and Option Agreement with UniQuest 15
Janssen Cilag Enters into Agreement with UniQuest 16
UniQuest Enters into Drug Discovery Agreement with AstraZeneca 17
Emory University Enters Into Joint Venture With UniQuest To Form Que Oncology 18
UniQuest Partners With Axiom Molecular 19
UniQuest Enters Into R&D Agreement With Axiom Molecular For Radiopharmaceuticals 20
Dendright Enters Into Research Agreement With Janssen-Cilag 21
Inflazome Enters into Licensing Agreement with Uniquest 22
Organovo Enters into Licensing Agreement with UniQuest 23
Ultragenyx Pharma Enters into Licensing Agreement with UniQuest for Triheptanoin 24
UniQuest Pty Ltd, Key Competitors 25
UniQuest Pty Ltd, Key Employees 26
UniQuest Pty Ltd, Subsidiaries 27
UniQuest Pty Ltd, Joint Venture 27

★海外企業調査レポート[UniQuest Pty Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Schwan Food Company:戦略・SWOT・企業財務分析
    The Schwan Food Company - Strategy, SWOT and Corporate Finance Report Summary The Schwan Food Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products include vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects comprise Sier …
  • Oriental Food Industries Holdings Berhad:企業の戦略・SWOT・財務分析
    Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Klepierre SA:企業のM&A・事業提携・投資動向
    Klepierre SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Klepierre SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Coherus BioSciences Inc (CHRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Litha Healthcare Group Ltd-医療機器分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Transcontinental Inc. (TCL.A):企業の財務・戦略的SWOT分析
    Transcontinental Inc. (TCL.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Onorach Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Onorach Ltd (Onorach) is a contract research organization that provides clinical support services. The organization service portfolio includes tailored clinical trial support, clinical plan development, protocol design, regulatory, quality management, clinical operations management, patient …
  • Quadrise Fuels International Plc (QFI):企業の財務・戦略的SWOT分析
    Quadrise Fuels International Plc (QFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • CSA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary CSA Medical Inc (CSA Medical) is a medical device company that offers cryotherapy devices. The company provides spray cryotherapy medical device solutions to simplify procedures, improve patient outcomes, and reduce the cost of healthcare. Its truFreeze system delivers cold liquid nitrogen s …
  • Lonestar Heart Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lonestar Heart Inc (Lonestar Heart) is a pharmaceutical company that focuses on the development of novel cardiac restorative therapies for advanced heart failure. The company offers Algisyl cardiac implantable hydrogel and MyoTec system. Its Algisyl product provides a new treatment option fo …
  • Acxiom Corporation:企業の戦略・SWOT・財務情報
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dermalogica Inc:企業の戦略・SWOT・財務情報
    Dermalogica Inc - Strategy, SWOT and Corporate Finance Report Summary Dermalogica Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • HUP-Zagreb d.d.:企業の戦略・SWOT・財務情報
    HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report Summary HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Medline Industries Inc-医療機器分野:企業M&A・提携分析
    Summary Medline Industries Inc (Medline) is one of the leading manufacturers and distributors of healthcare supplies in the US. It distributes products to diverse end users including hospitals, extended care facilities, surgery centers, home care dealers, home care agencies, commercial laundries, ph …
  • The Menarini Group:企業の戦略・SWOT・財務情報
    The Menarini Group - Strategy, SWOT and Corporate Finance Report Summary The Menarini Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Key Energy Services, Inc.:企業の戦略・SWOT・財務情報
    Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Saudi Arabian Oil Co:企業の戦略的SWOT分析
    Saudi Arabian Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Barilla Holding S.p.A.:企業の戦略・SWOT・財務情報
    Barilla Holding S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Barilla Holding S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sunbelt Transformer Ltd:電力:M&Aディール及び事業提携情報
    Summary Sunbelt Transformer Ltd (Sunbelt Transformer) is a provider of new and reconditioned transformers and electrical equipment for commercial and industrial markets. The company’s products include padmount transformers, substation transformers, dry-type transformers, pole-mount transformers, mot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆